Comparative efficacy of ciltacabtagene autoleucel versus idecabtagene vicleucel in the treatment of patients with relapsed or refractory multiple myeloma previously treated with 2-4 prior lines of therapy: a matching-adjusted indirect comparison.
- DOI
- 10.1080/03007995.2024.2391112
- Published
- 2024-08-22
- Container
- Curr Med Res Opin
- Publisher
- Not recorded
- Open access
- no
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1080/03007995.2024.2391112,
title = {Comparative efficacy of ciltacabtagene autoleucel versus idecabtagene vicleucel in the treatment of patients with relapsed or refractory multiple myeloma previously treated with 2-4 prior lines of therapy: a matching-adjusted indirect comparison.},
author = {Bar N and Diels J and van Sanden S and Mendes J and Hernando T and Burnett H and Cost P and Schecter JM and Lendvai N and Patel N and Ishida T and Er J and Harrison SJ and Lopez-Muñoz N.},
year = {2024},
journal = {Curr Med Res Opin},
doi = {10.1080/03007995.2024.2391112},
url = {https://doi.org/10.1080/03007995.2024.2391112}
}RIS
TY - JOUR TI - Comparative efficacy of ciltacabtagene autoleucel versus idecabtagene vicleucel in the treatment of patients with relapsed or refractory multiple myeloma previously treated with 2-4 prior lines of therapy: a matching-adjusted indirect comparison. AU - Bar N AU - Diels J AU - van Sanden S AU - Mendes J AU - Hernando T AU - Burnett H AU - Cost P AU - Schecter JM AU - Lendvai N AU - Patel N AU - Ishida T AU - Er J AU - Harrison SJ AU - Lopez-Muñoz N. PY - 2024 JO - Curr Med Res Opin DO - 10.1080/03007995.2024.2391112 UR - https://doi.org/10.1080/03007995.2024.2391112 ER -
APA
N, B., J, D., S, V. S., J, M., T, H., H, B., P, C., JM, S., N, L., N, P., T, I., J, E., SJ, H., & N., L. (2024). Comparative efficacy of ciltacabtagene autoleucel versus idecabtagene vicleucel in the treatment of patients with relapsed or refractory multiple myeloma previously treated with 2-4 prior lines of therapy: a matching-adjusted indirect comparison.. Curr Med Res Opin. https://doi.org/10.1080/03007995.2024.2391112
Source records
- europe-pmc · retrieved 2026-09-26T07:55:58.587Z